{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:20:00Z","timestamp":1779920400566,"version":"3.53.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province of China","doi-asserted-by":"crossref","award":["H2013115"],"award-info":[{"award-number":["H2013115"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Fund for Scientific and Technological Innovative Talents in Harbin","award":["2012RFQXS012"],"award-info":[{"award-number":["2012RFQXS012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.exger.2015.10.015","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T05:55:39Z","timestamp":1446530139000},"page":"244-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Galantamine attenuates amyloid-\u03b2 deposition and astrocyte activation in APP\/PS1 transgenic mice"],"prefix":"10.1016","volume":"72","author":[{"given":"Zhaoxuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.exger.2015.10.015_bb0005","doi-asserted-by":"crossref","first-page":"e89454","DOI":"10.1371\/journal.pone.0089454","article-title":"Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's Disease","volume":"9","author":"Bhattacharya","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2015.10.015_bb0010","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1096\/fj.09-141754","article-title":"Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition","volume":"24","author":"Chakrabarty","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.exger.2015.10.015_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/jpet.105.098566","article-title":"Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice","volume":"317","author":"Christina","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.exger.2015.10.015_bb0020","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.neuropharm.2011.01.035","article-title":"Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP\/PS1 mouse model of Alzheimer's disease","volume":"60","author":"Filali","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.exger.2015.10.015_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijdevneu.2014.06.011","article-title":"Galantamine, an acetylcholinesterase inhibitor, reduces brain damage induced by hypoxia\u2013ischemia in newborn rats","volume":"37","author":"Furukawa","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"issue":"1","key":"10.1016\/j.exger.2015.10.015_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000337458","article-title":"Impaired performance of female APP\/PS1 mice in the Morris water maze is coupled with increased A\u03b2 accumulation and microglial activation","volume":"11","author":"Gallagher","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.exger.2015.10.015_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00406-004-0558-2","article-title":"Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain","volume":"255","author":"Hampel","year":"2005","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"35","key":"10.1016\/j.exger.2015.10.015_bb0040","doi-asserted-by":"crossref","first-page":"11621","DOI":"10.1523\/JNEUROSCI.1405-14.2014","article-title":"Combined treatment with a BACE inhibitor and anti-A\u03b2 antibody gantenerumab enhances amyloid reduction in APP London mice","volume":"34","author":"Jacobsen","year":"2014","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.exger.2015.10.015_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.exger.2015.10.015_bb0050","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2004.10.132","article-title":"Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity","volume":"325","author":"Kihara","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exger.2015.10.015_bb0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer's disease","volume":"33","author":"Lee","year":"2010","journal-title":"Arch. Pharm. Res."},{"issue":"47","key":"10.1016\/j.exger.2015.10.015_bb0060","doi-asserted-by":"crossref","first-page":"36958","DOI":"10.1074\/jbc.M110.127829","article-title":"Overexpression of human apolipoprotein A-I preserves cognitive function and attenuatesneuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease","volume":"285","author":"Lewis","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.exger.2015.10.015_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2010.06.005","article-title":"Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells","volume":"80","author":"Li","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.exger.2015.10.015_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"McAlpine","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exger.2015.10.015_bb0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphys.2014.00463","article-title":"Molecular mechanism of the intramembrane cleavage of the \u03b2-carboxyl terminal fragment of amyloid precursor protein by \u03b3-secretase","volume":"5","author":"Morishima-Kawashima","year":"2014","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.exger.2015.10.015_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2008.10.020","article-title":"Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease","volume":"448","author":"Park","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.exger.2015.10.015_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Patel","year":"2005","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.exger.2015.10.015_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","article-title":"Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway","volume":"23","author":"Pavlov","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.exger.2015.10.015_bb0095","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.exger.2015.10.015_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2013.12.071","article-title":"The dual role of astrocyte activation and reactive gliosis","volume":"565","author":"Pekny","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.exger.2015.10.015_bb0105","first-page":"156","article-title":"Galantamine effect on tularemia pathogenesis in a BALB\/c mouse model","volume":"16","author":"Pohanka","year":"2012","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.exger.2015.10.015_bb0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-5728(03)00158-9","article-title":"Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons","volume":"139","author":"Qiu","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.exger.2015.10.015_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bmcl.2012.10.111","article-title":"Investigating the binding interactions of galantamine with \u03b2-amyloid peptide","volume":"23","author":"Rao","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.exger.2015.10.015_bb0120","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/gps.3966","article-title":"Blood pro-inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors","volume":"12","author":"Richardson","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2015.10.015_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2015.04.017","article-title":"Selective activation of alpha 7 nicotinic acetylcholine receptor by pha-543613 improves beta-amyloid 25\u201335 mediated cognitive deficits in mice","volume":"298","author":"Sadigh-Eteghad","year":"2015","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.exger.2015.10.015_bb0130","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nm.1872","article-title":"Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology","volume":"14","author":"Schilling","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.exger.2015.10.015_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)08675-4","article-title":"Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands","volume":"49","author":"Schrattenholz","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"51","key":"10.1016\/j.exger.2015.10.015_bb0140","doi-asserted-by":"crossref","first-page":"40180","DOI":"10.1074\/jbc.M110.142356","article-title":"Galantamine-induced amyloid-\u03b2 clearance mediated via stimulation of microglial nicotinic acetylcholine receptors","volume":"285","author":"Takata","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exger.2015.10.015_bb0145","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1517\/13543784.16.12.1987","article-title":"An update on the pharmacology of galantamine","volume":"16","author":"Villarroya","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"11","key":"10.1016\/j.exger.2015.10.015_bb0150","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.ajpath.2014.07.004","article-title":"MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP\/PS1 transgenic mice","volume":"184","author":"Weitz","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exger.2015.10.015_bb0155","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0166-4328(02)00192-4","article-title":"Differential learning abilities of 129T2\/Sv and C57BL\/6J mice as assessed in three water maze protocols","volume":"136","author":"Wolff","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.exger.2015.10.015_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12264-011-1015-7","article-title":"Biochemical and behavioral characterization of the double transgenic mouse model (APPswe\/PS1dE9) of Alzheimer's disease","volume":"27","author":"Xiong","year":"2011","journal-title":"Neurosci. Bull."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556515300772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556515300772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T08:17:11Z","timestamp":1748679431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556515300772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":32,"alternative-id":["S0531556515300772"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2015.10.015","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galantamine attenuates amyloid-\u03b2 deposition and astrocyte activation in APP\/PS1 transgenic mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2015.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}